MDNA (MDNA) News
Follow MDNA (MDNA) news in one place: company catalysts, earnings, analyst actions and wider market developments. Review 2 public stories across 2 publication days to understand how the story developed. Public news appears after a 15-minute delay; LiveCast subscribers can follow new headlines and hear important updates without this additional delay.
L
Medicenna Announces Oral Presentation of New Bizaxofusp Results in Recurrent Glioblastoma at the 2026 Society for Neuro-Oncology Annual Meeting
TORONTO and HOUSTON, Sept. 24, 2026 (GLOBE NEWSWIRE) -- Medicenna Therapeutics Corp. (“Medicenna” or the “Company”) (TSX: MDNA, OTCQX: MDNAF), a clinical-stage immunotherapy company developing Superkines for targeting ca
NEWS | Sep 24, 2026, 11:01 AM UTC
L
Medicenna to present at H.C. Wainwright 28th annual global conference
Medicenna Therapeutics Corp. announced it will present at the H.C. Wainwright 28th Annual Global Investment Conference.
EQUITY | Sep 03, 2026, 11:08 AM UTC